{"filing":{"accession_number":"0001213900-26-077575","cik":"0001954594","ticker":"HAO","company_name":"Haoxi Health Technology Ltd","form":"6-K","filing_date":"2026-07-13","report_date":null,"primary_document":"ea0297750-6k_haoxi.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1954594/000121390026077575/ea0297750-6k_haoxi.htm"},"events":[{"id":17598,"run_id":15765,"accession_number":"0001213900-26-077575","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 6-K discloses a registered direct offering completed on July 13, 2026, in which Haoxi issued 300,000 Class A ordinary shares at $0.40 per share and 9,700,000 pre-funded warrants (exercisable at $0.33) for gross proceeds of $4,000,000. This is a dilutive equity issuance that raises capital through the sale of registered securities, materially affecting share count and ownership structure. The disclosure explicitly states that 5,100,000 Class A shares were issued as of July 13, 2026, including shares from warrant exercises, representing a significant dilution to existing shareholders.","company_name":"Haoxi Health Technology Ltd","ticker":"HAO","filing_date":"2026-07-13","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":16135,"accession_number":"0001213900-26-077575","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 6-K discloses a registered direct offering completed on July 13, 2026, in which Haoxi issued 300,000 Class A ordinary shares at $0.40 per share and 9,700,000 pre-funded warrants (exercisable at $0.33) for gross proceeds of $4,000,000. This is a dilutive equity issuance that raises capital through the sale of registered securities, materially affecting share count and ownership structure. The disclosure explicitly states that 5,100,000 Class A shares were issued as of July 13, 2026, including shares from warrant exercises, representing a significant dilution to existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:16:38.136795+00:00","company_name":"Haoxi Health Technology Ltd","ticker":"HAO","filing_date":"2026-07-13"}]}